{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001648257","name":"HUTCHMED (China) Ltd","summary":"HUTCHMED (China) Ltd is a biopharmaceutical company focused on oncology and immunology. It develops, manufactures, and commercializes cancer and immunological drugs, including approved products Elunate, Fruzaqla, Sulanda, Orpathys, and Tazverik. The company operates primarily in China through HUTCHMED Limited and pursues global partnerships with AstraZeneca, Eli Lilly, Takeda, ImageneBio, and Miragene. It also holds interests in a pharmaceutical distribution business and equity investments in Shanghai Hutchison Pharmaceuticals.","people":[],"products":[{"name":"Elunate","type":"platform","description":"Approved oncology drug commercialized by HUTCHMED in China."},{"name":"Fruzaqla","type":"platform","description":"Approved oncology drug commercialized by HUTCHMED."},{"name":"Sulanda","type":"platform","description":"Approved oncology drug commercialized by HUTCHMED."},{"name":"Orpathys","type":"platform","description":"Approved oncology drug commercialized by HUTCHMED."},{"name":"Tazverik","type":"platform","description":"Approved oncology/immunology drug (EZH2 inhibitor) commercialized by HUTCHMED."}],"partnerships":[{"partner_name":"AstraZeneca","partnership_type":"strategic","description":"Strategic alliance involving milestone, royalty, service payments and manufacturing costs.","start_date":null},{"partner_name":"Eli Lilly","partnership_type":"strategic","description":"Strategic alliance involving milestone, royalty, service payments and manufacturing costs.","start_date":null},{"partner_name":"Takeda","partnership_type":"strategic","description":"Strategic alliance involving milestone, royalty, service payments and manufacturing costs.","start_date":null},{"partner_name":"ImageneBio","partnership_type":"strategic","description":"Strategic alliance involving milestone, royalty, service payments and manufacturing costs; formed from merger of Inmagene and Ikena Oncology in July 2025.","start_date":null},{"partner_name":"Miragene","partnership_type":"strategic","description":"Strategic alliance involving milestone, royalty, service payments and manufacturing costs.","start_date":null},{"partner_name":"Sinopharm","partnership_type":"strategic","description":"Holds remaining interest in Distribution Business, Shanghai Hutchison Whampoa Pharmaceutical Sales Limited.","start_date":null},{"partner_name":"Shanghai Pharmaceuticals","partnership_type":"strategic","description":"Joint venture partner in Shanghai Hutchison Pharmaceuticals Limited; HUTCHMED holds 5% interest after disposing 45% aggregate shareholding in April 2025.","start_date":null}],"affiliations":[],"origin":{"leaf":"f58a31e61329c1683cecca636f76fb328019d65006a0ce4d2635a64d046016bd","parent":"cf7182c1ac975bde41f5e11f38cc9e4fd781df3cdd6075045e7c0df9e1dd0585","timestamp":"2026-08-13T09:35:11.639Z","source":"0001104659-26-023822","chain":"SEC.gov PEM > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":197,"hourly_limit":500,"remaining":303,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}